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ABSTRACT 1 
Background: Heavy exercise causes gut symptoms and, in extreme cases, “heat stroke” due 2 
to increased intestinal permeability of luminal toxins.  3 
Objective: To examine whether zinc carnosine (ZnC) a health food product taken alone or in 4 
combination with bovine colostrum, a natural source of growth factors, moderated such 5 
effects. 6 
Design: 8 volunteers completed a four-arm double-blind, placebo-controlled, crossover 7 
protocol (14 days placebo, ZnC, colostrum, ZnC + colostrum) prior to standardized exercise 8 
undertaken 2 and 14 days after starting treatment. Changes in epithelial resistance, apoptosis 9 
signalling molecules and tight junction protein phosphorylation in response to 2°C rise were 10 
determined using Caco-2 & HT29 intestinal cells.  11 
Results: Body temperature increased 2°C and gut permeability (5 hour urinary 12 
lactulose:rhamnose ratios) increased 3-fold following exercise (0.32 ± 0.016 baseline to 1.0 + 13 
0.017 at +14 days, p<0.01). ZnC or colostrum truncated rise by 70% after 14 days treatment. 14 
Combination treatment gave additional benefit and truncated exercise induced increase at +2 15 
day (30% reduction, p<0.01). 2°C temperature rise in in vitro studies caused doubling of 16 
apoptosis and reduced epithelial resistance 3-4-fold. ZnC or colostrum truncated these effects 17 
(35-50%) with greatest response seen with combination treatment (all p<0.01). Mechanisms 18 
of action included increasing Hsp70 and truncating temperature-induced changes in B cell 19 
leukemia/lymphoma-2 associated X protein-alpha (Baxα) and B-cell lymphoma 2 (Bcl-2).  ZnC 20 
also increased total occludin and reduced phosphorylated Tyrosine (pTyr)-claudin, pTyr-21 
occludin and phosphorylated Serine (pSer)-occludin, enhancing tight junction formation and 22 
stabilisation. 23 
Conclusion: ZnC taken alone or with colostrum increased epithelial resistance and tight 24 
junction structure and may have value for athletes and preventing heat stroke in military 25 
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personnel. 26 
Keywords: Repair; gut growth; injury; nutriceutical; clinical trial 27 
INTRODUCTION 28 
Several stresses affect the integrity of the intestinal barrier including prolonged strenuous 29 
exercise (1), heat stress (2) and drugs such as nonsteroidal anti-inflammatory agents 30 
(NSAIDs)(3).  Loss of intestinal integrity may result in passage of luminal endotoxins into the 31 
circulation, causing an inflammatory cascade, exacerbating loss of barrier function. This can 32 
result in severe systemic effects (4), such as in exertional heat stroke, associated with 33 
hyperthermia, multi-organ failure and endotoxemia. Similar processes have relevance for 34 
many athletes involved in heavy exercise such as long-distance running where gastrointestinal 35 
symptoms including cramps, diarrhoea, nausea, and bleeding are commonly reported (5, 6).  36 
These symptoms are probably due to a combination of reduced splanchnic blood flow (7), 37 
hormonal changes, altered gut permeability, and increased body temperature. 38 
 39 
Pharmacological options to reduce these problems are limited, particularly in competitive 40 
athletics.  There is, therefore, interest in using natural or naturally derived products. One 41 
product already commercially available is zinc carnosine (ZnC), where zinc and carnosine are 42 
linked in a polymeric one-to-one ratio and is currently marketed as a zinc dietary supplement 43 
with “added value for gastric health”. Combining zinc with carnosine has potential 44 
advantages over simple zinc supplementation as carnosine is a dipeptide (comprising β-45 
alanine and l-histidine) that is naturally present in long living cells such as muscle and nerves, 46 
where, among other actions, it probably has a role as an antioxidant (8). 47 
 48 
We previously showed ZnC stimulates several aspects of gut mucosal integrity, including 49 
stimulating cell migration and proliferation in vitro and reducing the amount of gastric and 50 
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small intestinal injury caused by NSAIDs in rats and mice (9). Furthermore, using normal 51 
volunteers, we demonstrated that ZnC prevented the rise in gut permeability caused by 52 
clinical doses of the NSAID indomethacin (9).  Its potential value in decreasing gut 53 
permeability associated with heavy exercise and its mechanism of actions are, however, 54 
unknown.  55 
 56 
We now examine the effect of oral ZnC on gut permeability and exercise-induced temperature 57 
rise in subjects undertaking heavy exercise and compared effects of ZnC alone with taking it 58 
in combination with bovine colostrum, a rich source of growth factors and immune 59 
modulators (10). Our previous studies utilising colostrum alone showed benefit in reducing 60 
exercise induced increased gut permeability in athletes, but only after prolonged (14 days) 61 
administration (11). Colostrum given alone, therefore, also provided a useful positive control. 62 
 63 
To examine some of the mechanisms by which protective effects were mediated, we 64 
performed a series of in vitro studies using two human intestinal cell lines focusing on the 65 
effect of a temperature rise to 39oC (similar to that seen in athletes undergoing the in vivo 66 
studies) on apoptosis, epithelial barrier resistance, heat shock protein 70 (Hsp70) expression 67 
and tight junction (TJ) proteins in the presence and absence of test compounds. 68 
 69 
MATERIALS & METHODS 70 
Chemicals were purchased from Sigma (Poole, Dorset) unless otherwise stated.   71 
 72 
A) CLINICAL STUDY: EFFECT OF ZNC AND COLOSTRUM ON EXERCISE-73 
INDUCED CHANGES IN HUMAN GUT PERMEABILITY. 74 
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 75 
Zinc carnosine (Lonza Nutrition Inc USA) and indistinguishable placebo capsules were used 76 
for clinical study. Colostrum (Neovite brand lactose-reduced colostrum) and placebo were 77 
provided by Colostrum UK, London. Placebo used in place of colostrum was isoenergetic and 78 
isomacronutrient milk protein concentrate at 80% protein content (principally casein) and was 79 
indistinguishable in appearance and taste from the colostrum powder, which was the form 80 
administered.  81 
 82 
Ethical Approval: All procedures were conducted according to the Declaration of Helsinki. 83 
Ethics approval was obtained from Aberystwyth University Ethics Committee.  84 
 85 
Subjects: Eight healthy males took part and all were active individuals who exercised 86 
regularly 4 or more times per week (4 participants were runners, 1 cyclist, 1 lacrosse player, 1 87 
footballer, 1 rugby player). Physical parameters were: mean age 25, range 19-33; height 1.78 88 
± 0.02 m; body mass 80.1±2.5 kg; BMI 24.98±0.17 kg/m2; maximal oxygen uptake 89 
(VO2max) 59.6±1.8 ml/kg
/min; peak speed in VO2max test 18±0.4 km/h; running speed at 90 
80% VO2max 13.5±0.03 km/h; (values mean ± SEM). Subjects completed a pre-exercise 91 
screening questionnaire (Physical Activity Readiness Questionnaire: PAR-Q) before 92 
participating in each test. VO2max exercise assessments were performed by standard methods 93 
as reported previously (9) on day -5 of each arm to ensure consistency of the 80% VO2max 94 
protocol on day +2 and +14 (Figure 1 and 2). 95 
 96 
Preparation of subjects for the exercise study: Subjects completed a 24 h food diary on the 97 
day before the main exercise trial in the first arm of the trial and repeated this diet in the 98 
subsequent arms.. All trials were performed after an overnight fast of at least 10 h. Subjects 99 
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reported at 07:00 for all trials and self-positioned a rectal thermistor (Grant Instruments, 100 
Cambridge, England), 10 cm beyond the anal sphincter, and positioned a telemetric heart rate 101 
monitor transmitter band (Polar S610i, Polar Electro Oy, Tampere, Finland).  Core 102 
temperature (Tcore) was recorded using an electronic data logger (Squirrel SQ2020, Grant 103 
Instruments, Cambridge, England).   104 
Subjects sat for 10 min before baseline venous blood sample (pre-exercise) was taken. 105 
Subjects then ran on the treadmill, with 1% grade, for 20 min at a constant speed equivalent to 106 
80% VO2max, as determined from preliminary tests. Expired gas was analyzed during 107 
exercise using an online breath-by breath system (Jaeger Oxycon Pro. Hoechberg, Germany). 108 
Core body temperature, heart rate, and rating of perceived exertion were recorded every 5 min 109 
during the trial. After completing the run, subjects were quickly seated and a second blood 110 
sample (post-exercise) was obtained (within 5 minutes). Subjects then emptied their bladder 111 
before consuming the intestinal permeability test drink and commencing with a 5-h urine 112 
collection to determine intestinal permeability. 113 
 114 
Study design: In a four-arm double-blind placebo controlled randomised crossover design, 115 
subjects received oral supplementation twice a day for 14 days with a 14 day washout period 116 
between each study arm (Figure 1 and 2). Each arm was administered in a randomised fashion 117 
using the web site randomization.com (4x4 blocks). Timing was based on our previous 118 
studies using this type of protocol that had demonstrated was sufficient time to ensure 119 
baseline permeability values returned back to normal (11).  120 
Maximal oxygen uptake (VO2max) was assessed on day -5 for each arm of the study. Gut 121 
permeability assessments were performed under non- exercise conditions on day -2 and 0 (to 122 
  Davison et al 8 
confirm stable baseline) and immediately following the standardised exercise (treadmill 123 
running 20 min at 80% VO2max) protocol on day +2 and +14. 124 
Oral supplements consisted of 37.5 mg ZnC + 10 g placebo, 10 g bovine colostrum + placebo 125 
capsule, 37.5 mg ZnC + 10 g bovine colostrum and 10 g placebo + placebo capsule, taken 126 
twice per day. The capsules (ZnC) and powder (colostrum) or their placebo equivalents were 127 
taken just prior to breakfast or evening meal. The doses were chosen based on the results of 128 
pilot in vitro studies (Supplemental Material 1, Supplemental Figure 1).  129 
 130 
Analytical methods: Intestinal permeability was assessed using our previously published 131 
protocol, equipment and methods (11).  Results are expressed as a simple area under the curve 132 
ratios as described by us previously (11) and also as ratio of percentage of ingested sugar 133 
excreted in the urine as used by some other groups (12). 134 
 135 
B) IN VITRO STUDIES 136 
To investigate mechanisms by which test compounds influenced gut permeability in the 137 
clinical study, we performed a series of experiments examining the effect of a 2°C rise (from 138 
37 to 39°C). 139 
 140 
Cell lines: HT29 is derived from colorectal adenocarcinoma of 44-year-old Caucasian female 141 
(ATCC)(13). Caco-2 is derived from colorectal adenocarcinoma of 72-year-old male (ATCC) 142 
and exhibits tight junctions and desmosomes between adjacent cells and grows as polarized 143 
monolayers (14). 144 
 145 
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Transepithelial permeability assays: The influence of temperature changes on 146 
transepithelial permeability in the presence and absence of test factors were determined using 147 
two different methods.  One determined changes in transepithelial electrical resistance using 148 
our previously published methods (11). The other analysed the passage of horseradish 149 
peroxidase (HRP) across the epithelial layer using standard methods (15). To enhance any 150 
effects seen, the above experiments were also performed in low calcium medium (0.9 mM) in 151 
addition to normal calcium medium (1.7 mM). 152 
 153 
Heat shock protein 70 (Hsp70) assay: Effects of temperature change and various test factors 154 
on cell lysate Hsp70 levels were determined using our previously published methods (11), 155 
using a Duoset Elisa kit (DYC1663-2, R&D Systems Europe, Abingdon, UK).  156 
 157 
Cell apoptosis assays: Effects of temperature change and the various test factors on cell 158 
lysate levels of active caspase-3 (an effector caspase) and caspase-9 (an initiator caspase) 159 
were determined using methods previously described (11), using commercial colorimetric 160 
assay kits (BF3100 and BF10100, R&D Systems). In addition, Westerns were performed 161 
using caspase-3 (sc-7272, Santa Cruz) and caspase-9 (sc-81589) antibodies capable of 162 
detecting both pro-caspase and active caspase. Films were scanned and mean signal density of 163 
each band determined using Adobe Photoshop. 164 
 165 
Concentrations of the anti-apoptotic protein Bcl-2 and the pro-apoptotic protein Bax were 166 
determined in the same cell lysates as used for caspase analyses, using Duoset Elisa kits 167 
(DYC827B-2 and DYC820-2, respectively, R&D Systems Europe Ltd).  168 
 169 
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TJ protein and phosphorylation assessments: Effects of temperature change were assessed 170 
using standard assays and commercial kits: occludin, zona occludens protein 1 (ZO1) and 171 
claudin-1 (tight junction antibody samples pack 90-1200, Invitrogen), tyrosine, serine and 172 
threonine phosphorylation levels were measured by standard ELISA (anti-phosphothreonine 173 
ab9337, anti-phosphotyrosine ab9318 and anti-phosphoserine ab9332, all Abcam, Cambridge 174 
UK). In addition, Western analyses were performed for total occludin, ZO1 and claudin-1 and 175 
a commercial kit (35050, Thermo Scientific). Immunocomplexes were prepared from lysates 176 
by incubation with relevant TJ antibody and analysed by Western using anti-177 
phosphothreonine , anti-phosphotyrosine or anti-phosphoserine and a commercial kit (35050, 178 
Thermo Scientific). Films were scanned and the mean signal density of each band was 179 
determined using Adobe Photoshop. 180 
 181 
Statistical analyses 182 
All values are expressed as the mean + SEM unless stated. For in vitro studies, a JMP 183 
statistical package (version 10) was used to perform three way ANOVA with temperature, 184 
treatment and time as factors. For the clinical study, a three way ANOVA with treatment 185 
(arm), permeability and time as factors was performed. Where a significant effect was seen 186 
(p<0.05), individual comparisons were performed using t-tests based on the group means, 187 
residual and degrees of freedom obtained from the ANOVA, a method equivalent to repeated 188 
measures analyses (11). 189 
 190 
RESULTS 191 
A) CLINICAL STUDY: EFFECT OF ZNC AND COLOSTRUM ON EXERCISE-192 
INDUCED CHANGES IN HUMAN GUT PERMEABILITY. 193 
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As expected, rating of perceived exertion expressed during exercise, heart rate (mean rise 194 
106+2 BPM, from 73+1 to 179+1 BPM), lactate concentrations (mean rise 5.76+0.31 mM, 195 
from 1.10+0.07 to 6.86+0.31 mM), core temperature (mean rise 1.59+0.04 °C, from 196 
36.75+0.02 to 38.33+0.05 °C), VO2, VCO2 and respiratory exchange ratio, all rose in response 197 
to exercise (all p<0.01). The presence of supplements had no significant effect on results. 198 
VO2max assessments on day -5 of each arm and 80% VO2max protocol on day 2 and 14 were 199 
not different between the four arms (Table 1).   200 
 201 
Baseline permeability expressed as the ratio of Lactulose/Rhamnose under the curve values 202 
were similar at the beginning of each study arm (Figure 3). Permeability increased about 3-203 
fold in response to exercise during the placebo arm (rising from 0.318+0.016, initial baseline 204 
value, to 0.979+0.026 at day +2 and 1.000+0.017 at day +14 (both p<0.01 vs baseline).  205 
Expressing results as Lactulose/Rhamnose % urinary excretion ratios gave equivalent results 206 
(Supplemental Material 1, Supplemental Figure 2). 207 
After 2 days treatment, ingestion of ZnC alone or colostrum alone did not significantly reduce 208 
the rise in exercise induced permeability compared to placebo. In contrast, ingestion of ZnC + 209 
colostrum attenuated this increase in permeability by 30% (p<0.01 versus the other treatment 210 
groups arms at the same time point).  211 
After 14 days treatment, the increase in permeability caused by exercise was reduced by 71% 212 
in the ZnC alone arm, 68% in the colostrum alone arm and by 85% in the ZnC + colostrum 213 
arm (Figure 3, all p<0.01 vs placebo at same time point). ZnC + colostrum was significantly 214 
better at truncating the rise in permeability induced by exercise than using colostrum alone 215 
(p<0.05) and although it had a greater reductive effect than using ZnC alone, this difference 216 
was not statistically significant at the <0.05 level.  (p=0.069).  217 
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The order in which the arms were administered did not influence results (although numbers 218 
are too small to perform detailed statistical analysis).   219 
 220 
B. IN VITRO STUDIES  221 
Transepithelial permeability: Results examining electrical resistance (Figure 4A) or 222 
passage of HRP (Figure 4B) confirmed the protective effects of test substances. Using this 223 
protocol, the combination of ZnC + colostrum resulted in a significant beneficial effect (77% 224 
attenuation of increased permeability caused by temperature rise), which was greater than that 225 
seen when cells were incubated with either ZnC (52% attenuation) or colostrum (41% 226 
attenuation) given alone (Figure 4A and B).  227 
 228 
Apoptosis:  Both ELISA and western blot analysis showed that increasing incubation 229 
temperature caused an approximate 2-fold increase in active caspase 3 and 9 expression at the 230 
8 h time points (Figure 5 and Supplemental Figure 3).  Addition of ZnC, colostrum or ZnC 231 
+ colostrum had no significant effect on caspase expression when incubated at 37°C.  232 
However, the co-presence of ZnC, colostrum or the combination all significantly reduced 233 
caspase 3 and 9 expression compared to cells grown in medium alone at 39°C  (all p<0.01).  234 
These changes were specific as they were not seen when the capase-3 or caspase-9 inhibitor 235 
were also added to the cells (Supplemental Figure 4).  236 
 237 
The 2°C rise caused increased Bax concentration from 578.6+16.7 to 797.4+29.7 pg/ml 238 
(p<0.01) at the 4 h time point (Figure 6A). Addition of ZnC alone did not affect Bax 239 
expression at either 37 or 39°C whereas colostrum alone did reduce the temperature-induced 240 
rise in Bax. A significant further decrease in Bax concentration was seen when ZnC and 241 
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colostrum were added together at 39°C (p<0.01 vs ZnC alone, Figure 6A Similar results 242 
were seen after 8h (data not shown). 243 
 244 
The 2°C rise resulted in a decrease of Bcl2 levels from 350 + 2 to 292 + 2 pg/ml to (p<0.01) 245 
after 4 h (Figure 6B). Addition of ZnC, colostrum or the combination did not affect Bcl2 246 
levels at 37°C. At 39°C, the presence of ZnC or colostrum alone significantly attenuated the 247 
temperature-induced decrease in Bcl2 levels and an additive/synergistic effect was seen when 248 
ZnC and colostrum were added together, completely preventing the temperature induced 249 
decline in Bcl2. Similar results were seen after 8h (data not shown). 250 
 251 
Raising incubation temperature caused increased Hsp70 levels from 139 +1 to 181+3 pg/ml 252 
(p<0.01) after 4 h (Figure 6C). Adding ZnC alone or colostrum alone increased Hsp70 levels 253 
at both 37°C and 39°C above values seen in cells grown in medium alone (all p<0.05). 254 
Compared to giving either test compound alone, additional increases were found when ZnC 255 
and colostrum were added together in cells at 39°C at both time points (Figure 6C+D).   256 
 257 
TJ protein expression and phosphorylation: As results at 4h were similar to those at 8h, 258 
they are reported together below. 259 
 260 
ZO1:  Total ZO1 increased in response to temperature rise and were not affected by test 261 
factors (Figure 7A). P-Tyr-ZO1 were reduced by temperature rise and presence of colostrum 262 
or combination treatment reduced levels further (Figure 7B). P-Ser-ZO1 was reduced by 263 
temperature rise. The co-presence of test factors increased p-Ser-ZO1 levels at both 37 and 264 
39°C (Figure 7C). Analyses using Western blotting and densitometry showed similar results 265 
(Supplemental Figure 5). 266 
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 267 
Occludin: Total occludin increased in response to temperature rise. Presence of ZnC, 268 
colostrum or combination all increased total occludin levels at 37°C. At 39°C all test factors 269 
caused additional rises in total occludin levels compared to cells in medium alone (Figure 270 
8A).  Increased temperature caused p-Tyr-occludin to rise but presence of test factors reduced 271 
p-Tyr-occludin levels at both 37 and 39°C with largest fall seen in cells treated with ZnC + 272 
colostrum (Figure 8B).  P-Ser-occludin levels were reduced in response to temperature rise 273 
and presence of test factors caused further reductions in p-Ser-occludin ratios, with the largest 274 
fall seen with combination treatment (Figure 8C). Analyses using Western blotting and 275 
densitometry showed similar results (Supplemental Figure 6). 276 
 277 
Claudin-1: Total claudin-1 was not affected by temperature change or test factors (Figure 278 
9A). P-Tyr-claudin-1 levels rose in response to temperature increase and there was a small but 279 
significant truncation of the rise in the presence of ZnC alone or in combination with 280 
colostrum (Figure 9B). P-Ser-claudin-1 was not significantly affected by temperature rise or 281 
presence of test factors (Figure 9C). Analyses using Western blotting and densitometry 282 
showed similar results (Supplemental Figure 7). 283 
 284 
  285 
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DISCUSSION 286 
Using a combination of a clinical trial and in vitro experiments, we showed that ZnC 287 
attenuates the exercise-induced increase in gut permeability through mechanisms that include 288 
reducing temperature-induced apoptosis, induction of Hsp70 and modulation of TJ protein 289 
expression and phosphorylation. Enhanced results were seen if the ZnC was co-administered 290 
with another natural bioactive nutriceutical product; bovine colostrum.  291 
 292 
Numerous exercise protocols are used by exercise physiologists. We chose a 20-min run at 293 
80% VO2max protocol as we have previous experience of this (11), it allows a crossover 294 
study design to be used in a relatively short period, reliably increases gut permeability by 2-3 295 
fold and increases core temperature by 1.5–2°C. Assessment of intestinal permeability by 296 
quantitating unmediated absorption of at least two sugars of different sizes provides a 297 
sensitive index of intestinal damage as we and others have previously shown (11, 12, 16).  298 
 299 
Subjects’ VO2max and speed at 80% VO2max remained consistent for all arms and similar 300 
exercise-induced changes in core temperatures were observed in each study arm.  The 301 
protective effect of test substances could, therefore, not be attributed to changing core 302 
temperature during exercise. Gut permeability increased 3-fold in response to exercise in the 303 
placebo control arm, as expected using this protocol (11). These changes in gut permeability 304 
are similar to those reported by us previously in subjects ingesting clinically relevant doses of 305 
the NSAID indomethacin (9), which is known to cause small intestinal injury (17). 306 
 307 
Similar levels of protection, as determined by gut permeability, were seen when either ZnC or 308 
colostrum were administered alone with no protective effect seen after 2 days treatment but 309 
reducing permeability values by 70% after 14 days treatment. At this +14 day time point, 310 
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additional advantage was seen with combination treatment and, possibly more importantly in 311 
regards to the use by athletes or military entering a high temperature environment, 312 
combination treatment also attenuated exercise induced gut permeability after only 2 days 313 
treatment.  314 
 315 
We then undertook a series of in vitro studies to examine the effect of the core temperature 316 
rise on gut integrity in a controlled environment. We used two well validated complementary 317 
models to examine changes in trans-epithelial resistance by following changes in electrical 318 
resistance (11) and passage of a large molecule (HRP) across polarized monolayers of human 319 
colonic cancer cells (15). We have experience of studying effects of proteins in these systems 320 
and it removes confounding factors such as changes in blood flow. The results were 321 
consistent with the clinical trial; temperature rise was associated with increased permeability 322 
but this effect could be attenuated by the co-presence of ZnC +/- colostrum, with greatest 323 
effects seen with combination treatment. These effects are likely to be due, at least in part, to 324 
effects on paracellular permeability, such as alteration in TJs (18) and changes in apoptosis. 325 
 326 
Temperature rise is a well-known trigger of apoptosis (11), and we measured active caspase-3 327 
and 9 to examine potential effects of test compounds. We showed that this 2°C rise was 328 
sufficient to increase apoptosis and that ZnC truncated this response, possibly by maintaining 329 
levels of the anti-apoptotic protein Bcl-2. An additive effect was seen in the maintenance of 330 
Bcl-2 when ZnC and colostrum were added together. 331 
 332 
Hsps maintain cellular homeostasis during normal cell growth and enhance survival during 333 
and after various cellular stresses (19).  Increased Hsp expression may be one mechanism 334 
through which thermo-tolerance occurs in animals and cells (20). Hsp70 is increased in 335 
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response to temperature rises as a homeostatic mechanism for maintaining viability under 336 
conditions that increase the accumulation of damaged proteins. Our finding that ZnC induced 337 
Hsp70 expression at 37°C and caused additional increases when added at 39°C suggests that 338 
this pathway may have relevance to our results. Importantly, our in vitro results were 339 
demonstrated reproducing the temperature rise seen in the clinical study (to ∼39°C), and seen 340 
in most athletes during standard performance, rather than the typical 41.5°C used in rat 341 
models of hyperthermia that results in massive breakdown of mucosal integrity. 342 
 343 
Intestinal epithelial TJs are multi-protein complexes that connect adjacent cells on apical and 344 
lateral membranes and act as selective barriers. TJ integrity is regulated by assembly of 345 
extracellular loops of transmembrane proteins occludin and claudin and several intracellular 346 
plaque proteins such as ZO-1 which link to the actin cytoskeleton. TJ function is regulated by 347 
changes in both absolute amounts and degree of phosphorylation at specific residues. In 348 
general terms, increased expression of occludin, claudin and/or ZO-1 increase TJ formation 349 
and increase resistance (for good overview see 21, 22). Increased total occludin in response to 350 
ZnC can, therefore, be considered as potentially beneficial. Tyr phosphorylation of any of the 351 
three TJ proteins assessed hinders TJ formation, reducing epithelial resistance. Our finding 352 
that ZnC reduced pTyr levels of claudin and occludin should therefore enhance TJ formation 353 
although it should be noted that the changes in claudin phosphorylation in response to 354 
treatment were small and, therefore, of unclear significance. Similarly, our finding that ZnC 355 
reduced phosphorylation of serine in occludin should also enhance TJ formation.  356 
 357 
We showed that the overall effect of giving bovine colostrum alone or ZnC alone were similar 358 
in reducing exercise induced permeability. Both compounds increased Hsp70 levels and 359 
reduced heat induced apoptosis, although the signalling processes somewhat different with 360 
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colostrum, but not ZnC, reducing the temperature- induced rise in Bax levels. Analyses of 361 
TJ modulation also showed broadly similar results in phosphorylation effects on the TJ 362 
proteins although some differences, such as reduced pTyr of ZO-1 by colostrum, but not by 363 
ZnC, were seen.  364 
 365 
There is currently demand by the general public for more natural types of products, often 366 
termed “alternative-”,“complementary-” therapies or “nutriceuticals” (from nutrition and 367 
pharmaceuticals). Because of their natural origin, the general public often assume they are 368 
safe and may take high doses for prolonged periods. Caution needs to shown, however, as 369 
there is biological activity in many of these products, such as colostrum which is rich in 370 
multiple growth factors. (see 23)  The general principals of using the lowest dose for the 371 
shortest time possible, therefore, seems appropriate. In the current studies, ZnC was 372 
administered at 37.5 mg twice daily, giving total daily dose of zinc of 16 mgs/day. Current 373 
recommendations for daily zinc intake are 5.5-9.5mg (male) and 4-7mg (female) from UK 374 
food standards authority and 11mg (male) and 8 mg (female) from US NIH with daily upper 375 
recommended limits being 25mg/day in UK and 40 mg/day in US. The regimen used in the 376 
current studies is therefore well within safety guidelines.  377 
 378 
The findings of additive or synergistic effects (dependent on parameter) are particularly 379 
relevant in the clinical study as it was only combination treatment that was effective after 2 380 
days treatment. This suggests that short courses, taken for a few days before embarking on 381 
prolonged heavy exercise (such as athletic events or military manoeuvres in hot climates) 382 
could provide optimal results while minimising dosing. Further studies appear warranted to 383 
explore these findings. These could include examination of athletes undertaking prolonged 384 
strenuous exercise, such as a marathon where it would also be of interest to examine blood 385 
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endotoxin levels. It would also be of interest to examine additional markers of cellular 386 
integrity and enterocyte permeability such as I-FABP, although it seems likely that later blood 387 
samples and potentially a longer exercise protocol than that used in our studies would be 388 
required to demonstrate such changes (24). Additional studies could also include the 389 
relevance of hypoxia on paracellular and cellular integrity when cells are stressed by hypoxia 390 
alone and in combination with temperature rises.  Our current studies focusing on temperature 391 
change builds on previous work showing ZnC prevents NSAID gut damage. It would 392 
therefore be of interest to examine its effects on other gut disorders such as inflammatory 393 
bowel disease where uncontrolled inflammatory response combined with disruption of 394 
epithelial integrity is a major factor.  395 
 396 
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 Table 1. VO2max and 80% VO2 max exercise assessments. 
 Day -5 of trial 
VO2max protocol 
Day 2 of trial 
80% VO2max 
protocol 
Day 14 of trial 
80% VO2max 
protocol 
Placebo +Placebo 5.01 (4.44 – 5.11) 3.73 (3.31 – 3.89) 3.61 (3.26 – 3.79) 
Colostrum + Placebo 4.77 ( 4.50 – 4.93) 3.54 (3.25 - 3.77) 3.48 (3.19 – 3.69) 
 ZnC + Placebo 4.73 (4.57 – 5.06) 3.53 (3.34 – 3.78) 3.45 (3.29 – 3.73) 
ZnC + Colostrum  4.78 (4.61 – 4.89) 3.458 (3.35 – 3.70) 3.54 (3.36 – 3.58) 
1There were no significant differences between any of the treatment arms.  
2 Data shown as median and interquartile range (n=8) 
3 Data analyzed by 3-way ANOVA followed by t-tests based on the group means, residual 
and degrees of freedom obtained from the ANOVA. 
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FIGURE LEGENDS 
Figure 1. Consort Flowchart for randomised trial. 
Figure 2. Schematic of trial design. 
Each subject took part in a double blind cross over protocol. Subjects received oral 
supplementation twice a day with ZnC, bovine colostrum, ZnC + bovine colostrum or placebo 
for 2 weeks with a 2-week washout in between study arms. The timings used to determine 
O2max and to undertake 80% O2max protocols, gut permeability assessments (involving 5 h 
urine collection) and blood samples are shown. 
 
Figure 3. Gut permeability assessments during trial shown in Figure 2.  
Two baseline assessments (no exercise) were performed before each arm of the study. Tests 
products were started on day 0.  The other 2 assessments were performed at the end of 2 and 
14 days ingestion of placebo (), ZnC (X), colostrum () or ZnC + colostrum () 
immediately after the subject had followed a 20 min 80% VO2max protocol. Results are 
expressed as Lactulose/Rhamnose area under the curve ratio. Data expressed as mean +/-SEM 
(n=8). Data analysed by 3 way ANOVA  followed by t-tests based on the group means, 
residual and degrees of freedom obtained from the ANOVA. ** signifies p<0.01 compared 
the placebo arm at the same timepoint, ++ signifies p<0.01compared to ZnC arm at that 
timepoint, $ and  $$ signifies p<0.05 and p<0.01, respectively, compared to colostrum arm at 
that timepoint .  
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Figure 4. Effect of ZnC +/- colostrum on temperature induced changes in transepithelial 
electrical resistance and permeability to Horse radish peroxidase using Caco-2 
monolayers. 
A) Transepithelial resistance was measured in confluent polarised monolayers after 
incubating at 37 or 39oC for 8 hours.  
B) Permeability through the monolayers was also assessed by the measurement of passage of 
HRP into the basal medium, having been added to the apical medium at time zero. 
Data expressed as mean +/-SEM (n=4). Data analysed by 3 way ANOVA followed by t-tests 
based on the group means, residual and degrees of freedom obtained from the ANOVA. ** 
signifies p<0.01, respectively compared to medium alone at the same temperature, + and ++ 
signifies p<0.05 and p<0.01 compared to ZnC alone at the same temperature. $$ signifies 
p<0.01 compared to colostrum alone .  p<0.01 for all test conditions,  37°C vs 39°C  
 
Figure 5. Effect of ZnC +/- colostrum on temperature induced apoptosis, active caspase 
3 and 9.  
Caco-2 cells were incubated at 37 or 39°C for 8 hours in medium alone or with ZnC, 
colostrum or ZnC + colostrum. Changes in apoptosis were determined using active caspase-3 
(A) & 9 (B) assay kits, following changes in absorbance at 405 nM. Studies were also 
analysed using western analysis and showed similar results (Supplemental Figure 3). Data 
expressed as mean +/-SEM (n=3). Data analysed by 3 way ANOVA followed by t-tests based 
on the group means, residual and degrees of freedom obtained from the ANOVA. * and ** 
signifies p<0.05 and p<0.01 compared to medium alone at the same temperature and 
timepoint, respectively. p<0.01 for all test conditions 37°C vs 39°C  
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Figure 6.  Effect of ZnC +/- colostrum on temperature induced changes in the pro-
apoptotic protein Baxα, the anti-apoptotic protein Bcl-2 and heat shock protein 
expression (Hsp70).  
Caco-2 cells were incubated at 37 or 39°C in medium alone or with ZnC, colostrum or ZnC + 
colostrum. Changes in Baxα, (A), Bcl-2 (B) after 4h are shown. Changes seen in Hsp70 after 
4h (C) or 8h (D) incubation at these two temperatures are also shown.  Similar results were 
seen using HT29 cells (data not shown) 
 Data expressed as mean +/-SEM (n=3). Data analysed by 3 way ANOVA followed by t-tests 
based on the group means, residual and degrees of freedom obtained from the ANOVA.* and 
** signifies p<0.05 and p<0.01, respectively compared to medium alone at the same 
temperature and timepoint,++ signifies p<0.01 compared to ZnC alone at the same 
temperature and timepoint,  $ and $$ signifies p<0.05 and p<0.01, respectively compared to 
colostrum alone at the same temperature and timepoint. p<0.01 for all test conditions,  37°C 
vs 39°C  
 
Figure 7. Effect of ZnC +/- colostrum on temperature induced changes of ZO1 protein 
levels and phosphorylation. 
Cells were incubated in the presence of test factors for 8 h at either 37 or 39°C.  
A) Total ZO1, B) Phospho-tyrosine ZO1, C) Phospho-serine ZO1 analysed by Elisa. Studies 
using Western blotting and densitometry gave similar results (Supplemental Figure 5). Data 
expressed as mean +/-SEM (n=3). Data analysed by 3 way ANOVA followed by t-tests based 
on the group means, residual and degrees of freedom obtained from the ANOVA. ** signifies 
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p<0.01, respectively compared to medium alone at the same temperature, ++ signifies p<0.01, 
respectively compared to ZnC  alone at the same temperature. 
 
Figure 8. Effect of ZnC +/- colostrum on temperature induced changes of occludin 
protein levels and phosphorylation. 
Cells were incubated in the presence of test factors for 8 h at either 37 or 39°C.  
A) Total occludin,  B) Phospho-tyrosine occludin, C) Phospho-serine occludin analysed by 
Elisa. Studies using Western blotting and densitometry gave similar results (Supplemental 
Figure 6). Data expressed as mean +/-SEM (n=3). Data analysed by 3 way ANOVA followed 
by t-tests based on the group means, residual and degrees of freedom obtained from the 
ANOVA. * and ** signifies p<0.05 and p<0.01, respectively compared to medium alone at 
the same temperature, +  signifies p<0.05, respectively compared to ZnC alone at the same 
temperature,  $ signifies p<0.05 compared to colostrum alone at the same temperature. 
 
Figure 9. Effect of ZnC +/- colostrum on temperature induced changes of claudin 1 
protein levels and phosphorylation. 
Cells were incubated in the presence of test factors for 8 h at either 37 or 39°C.  
A) Total claudin-1, B) Phospho-tyrosine claudin-1, C) Phospho-serine claudin-1 analysed by 
elisa. Studies using Western blotting and densitometry gave similar results (Supplemental 
Figure 7). Data expressed as mean +/-SEM (n=3). Data analysed by 3 way ANOVA followed 
by t-tests based on the group means, residual and degrees of freedom obtained from the 
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ANOVA. ** signifies p<0.01, respectively compared to medium alone at the same 
temperature. 
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